Jfl Life Sciences Limited — Board Meeting, 27-03-2025: Outcome of Board Meeting

The Board of Directors has announced a board meeting outcome where they approved a rights issue to raise funds through the issuance of equity shares valued up to ₹49.50 crore. The specific terms, price, and ratio will be determined later. Additionally, Ms. Hiral Chudasama has been appointed as the Company Secretary and Compliance Officer, effective from March 28, 2025. This strategic move aims to enhance corporate governance and compliance within the company.